Company: CI
Filing Date: 2025-10-30
Form Type: 10-Q
Source: 0001739940-25-000037
Chunk: 319

Company: Cigna Group
Filing Date: 2025-10-30
Form: 10-Q
Item: Part II, Item 3
Chunk 319
---
 EliminationsTotalNine months ended September 30, 2024Revenues from external customers $144,689 $35,752 $333 $2 $180,776 Intersegment revenues3,558 3,606 63 (7,227)Net investment (loss) income(18)463 231 20 696 Total revenues148,229 39,821 627 (7,205)181,472 Net investment results from certain equity method investments— (238)— — (238)Special item related to impairment of dividend receivable182 — — — 182 Adjusted revenues$148,411 $39,583 $627 $(7,205)$181,416 Pharmacy and other service costs140,458 — Medical costs— 27,886 Selling, general and administrative expenses2,825 7,986 Other segment items (1)Interest (expense) and other(2)7 Less: Income attributable to noncontrolling interests271 — Pre-tax adjusted income (loss) from operations4,855 3,718 (4)(1,269)7,300 Income (loss) before income taxes$1,494 $3,221 $(9)$(1,446)$3,260 Pre-tax adjustments to reconcile to adjusted income from operations(Income) attributable to noncontrolling interests(271)— — — (271)Net investment losses (2)2,203 359 5 — 2,567 Amortization of acquired intangible assets1,247 32 — — 1,279 Special itemsIntegration and transaction-related costs— — — 177 177 Loss on sale of businesses— 106 — — 106 Impairment of dividend receivable 182 — — — 182 Pre-tax adjusted income (loss) from operations$4,855 $3,718 $(4)$(1,269)$7,300 Other segment informationDepreciation and amortization$1,764 $334 $7 $24 $2,129 (1)Other segment items represent the difference between segment adjusted revenues less significant segment expenses and pre-tax adjusted income (loss) from operations, and they do not represent significant segment items relative to the CODM's review and oversight.(2)Includes Net investment gains